Proteome Sciences plc (AIM:PRM)
London · Delayed Price · Currency is GBP · Price in GBX 1.770
+0.040 (2.31%)
Mar 6, 2026, 4:24 PM GMT
Proteome Sciences Market Cap
Proteome Sciences has a market cap or net worth of 6.07 million as of March 6, 2026. Its market cap has decreased by -54.42% in one year.
Market Cap
6.07M
Enterprise Value
21.20M
Revenue
4.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.77
Market Cap Chart
Since March 1, 1999, Proteome Sciences's market cap has decreased from 11.17M to 6.07M, a decrease of -45.69%. That is a compound annual growth rate of -2.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 6.07M | -17.78% |
| Dec 31, 2025 | 7.38M | -26.47% |
| Dec 31, 2024 | 10.04M | -24.94% |
| Dec 29, 2023 | 13.37M | 29.43% |
| Dec 30, 2022 | 10.33M | -31.71% |
| Dec 31, 2021 | 15.13M | 32.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 234.01B |
| GSK plc | 84.79B |
| Haleon | 34.46B |
| Smith & Nephew | 11.35B |
| Futura Medical | 7.28M |
| IXICO | 7.27M |
| CRISM Therapeutics | 6.21M |
| Feedback | 6.02M |